Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for ULORIC
- Role of Uralyt-U in Patients With Hyperuricemia
- A Study to Assess the Effect of Intensive Uric Acid (UA) Lowering Therapy With RDEA3170, Febuxostat, Dapagliflozin on Urinary Excretion of UA
- Compare the Renal Protective Effects of Febuxostat and Benzbromarone in CKD Chinese Patients
- Effect of Allopurinol and Febuxostat on Urinary 2,8-Dihydroxyadenine Excretion
- Compare the Renal Protective Effects of Febuxostat and Benzbromarone
- Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout
- Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout and Moderate Renal Impairment
- The Blood Pressure Effects of Febuxostat in Patients Previously Treated With Allopurinol: A Pilot Study
- Effects of Hyperuricemia Reversal on Features of the Metabolic Syndrome
- Effect of Febuxostat Compared to Placebo on Exercise Tolerance in Participants With Chronic Stable Angina
- Effect of Febuxostat on Blood Pressure
- Study of Febuxostat Effect on Blood Pressure in Patients With High Normal Blood Pressure
- Open Label Safety/Efficacy Study of Arhalofenate in Combination With Febuxostat for Hyperuricemia in Gout Patients
- Effects of Febuxostat on Adipokines and Kidney Disease in Diabetic Chronic Kidney Disease
- Febuxostat, Blood Pressure and the Intrarenal Renin-Angiotensin System (RAS)
- An Assessment of Chronic Synovial-Based Inflammation and Its Role With Serum Urate Levels.
- Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)
- Effect of Febuxostat on Renal Function in Patients With Gout and Moderate to Severe Renal Impairment
- Effect of Febuxostat on Joint Damage in Hyperuricemic Subjects With Early Gout
- Febuxostat Versus Allopurinol or Placebo in Patients With Hyperuricosuria and Calcium Oxalate Stones
- Study of Tranilast Alone or in Combination With Febuxostat in Patients With Hyperuricemia
- Efficacy and Safety of Oral Febuxostat in Participants With Gout
- Allopurinol Versus Febuxostat in Subjects Completing the Phase 3 Trials C02-009 or C02-010
- Dose-Response, Safety and Efficacy of Febuxostat in Subjects With Gout
- Long-Term Safety of Febuxostat in Subjects With Gout.
- Phase 3, Febuxostat, Allopurinol and Placebo-Controlled Study in Gout Subjects.
- Febuxostat Versus Allopurinol Control Trial in Subjects With Gout
Clinical trials list
click for details